Adriana Rossi - Hematology-Oncology | Mount Sinai

About Me

Adriana Rossi, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) and Co-director, CAR T and Stem Cell Transplant at the Center of Excellence for Multiple Myeloma.Dr. Rossi has extensive experience treating patients with multiple myeloma and precursor conditions (smoldering myeloma and MGUS), and other plasma cell disorders. She also has special expertise in cellular therapy. In addition to providing compassionate care to patients, Dr Rossi leads a number of clinical trials, with a focus on CART (chimeric antigen receptor T-cell) protocols. Prior to joining Mount Sinai in 2021, Dr. Rossi was Associate Clinical Director of the Myeloma Center at Weill Cornell, where she also served as the physician lead for cellular therapy in multiple myeloma.

The state of Florida requires out-of-state professionals who are registered to provide telehealth services to display a hyperlink to the Florida Department of Health telehealth web page. This allows Florida patients who are receiving medical care by telehealth to confirm the provider’s licensure and Florida registration.

Language

English, Italian, French, Portuguese, Spanish

Position

ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology

Hospital Affiliations

Mount Sinai Morningside
Mount Sinai Beth Israel
Mount Sinai Brooklyn
Mount Sinai Queens
The Mount Sinai Hospital
Mount Sinai West

Clinical Focus

AL Amyloidosis
Bone Marrow Transplantation, Autologous
CAR T Cell Therapy
Chemotherapy
Chimeric Antigen Receptor Therapy
Monoclonal Gammopathy of Uncertain Significance (MGUS)
Multiple Myeloma
Waldenström's Macroglobulinemia

Education

MD, George Washington University School of Medicine

MD, thomas jefferson

Fellowship, Hematology & Oncology

New York Presbyterian Hospital-Weill Cornell Center

Certifications

American Board of Internal Medicine

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, New York, NY, 10029

212-241-7873

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Healthfirst Medicare Advantage insurance: Effective 9/1/2024, Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.

Ruttenberg Treatment Center1470 Madison Avenue, New York, NY, 10029

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Rossi during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Bristol-Myers Squibb
Karyopharm, Inc.
Sanofi Aventis
Adaptive Biotechnologies
Janssen Pharmaceuticals

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.